Assignee
YAFEI SHANGHAI BIOPHARMACEUTICAL CO LTD
CN·2 granted patents·1 pending application·0 citations·filing 2013–2020
Top patents by PatentIndex Score
3 records- 0144US11319341B2Immune-stimulating soluble doxorubicin-conjugated complexYAFEI SHANGHAI BIOPHARMACEUTICAL CO LTD·Filed 2020·Granted May 3, 2022·0 cites·7 claims
- 0240US9982011B2Legumain activated doxorubicin derivative as well as preparation method and application thereofYAFEI SHANGHAI BIOPHARMACEUTICAL CO LTD·Filed 2013·Granted May 29, 2018·0 cites·14 claims
- 0337US2019135858A1Legumain Activated Doxorubicin Derivative as well as Preparation Method and Application ThereofYAFEI SHANGHAI BIOPHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when YAFEI SHANGHAI BIOPHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →